Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012168 · ClinicalTrials.gov registry record · NA
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
NCT00012168: Completed NA study, sponsored by NYU Langone Health.
NCT00012168 is a NA study that has completed, run by NYU Langone Health. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012168, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
Interventions
- GENETIC polymerase chain reaction
- OTHER immunohistochemistry staining method
- PROCEDURE radionuclide imaging
- PROCEDURE lymphangiography
- DRUG isosulfan blue
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-05 |
| Phase | NA |
What the finished NCT00012168 record still lists
NCT00012168 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which polymerase chain reaction is the first listed.
NCT00012168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00012168 about?
NCT00012168 is a clinical study titled "Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat". RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node met...
What is the current status of trial NCT00012168?
This trial is currently completed. It is a NA study. The study started on 1999-05.
What interventions are being tested in trial NCT00012168?
The interventions under investigation include: polymerase chain reaction (GENETIC), immunohistochemistry staining method (OTHER), radionuclide imaging (PROCEDURE), lymphangiography (PROCEDURE), isosulfan blue (DRUG).
Who is sponsoring clinical trial NCT00012168?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia